We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register to chat with like-minded investors on our interactive forums.
| Share Name | Share Symbol | Market | Type |
|---|---|---|---|
| Cel Sci Corporation New | AMEX:CVM | AMEX | Common Stock |
| Price Change | % Change | Share Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|
| 0.12 | 7.36% | 1.75 | 1.80 | 1.60 | 1.67 | 467,987 | 23:34:38 |
From May 2019 to May 2024
CEL-SCI Corporation (NYSE American: CVM), announces Geert Kersten, Chief Executive Officer, will present today at the 19th Annual Rodman & Renshaw Global Investment Conference at 2:10 PM. The presentation will be webcast live. To access the webcast, please visit the Investor Relations Section of CEL-SCI’s website www.cel-sci.com. The webcast replay will remain available for 90 days following the live presentation.
About CEL-SCI Corporation
CEL-SCI's work is focused on finding the best way to activate the immune system to fight cancer and infectious diseases. The Company has operations in Vienna, Virginia, and in/near Baltimore, Maryland.
View source version on businesswire.com: http://www.businesswire.com/news/home/20170911005090/en/
CEL-SCI CorporationGavin de Windt, 703-506-9460
1 Year Cel Sci Chart |
1 Month Cel Sci Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
